Dec 7, 2019
Reason | Investing in the Age of Longevity 2019
Posted by John Davies in categories: biotech/medical, finance, life extension
Gene therapies to reverse immunosenescence and atherosclerosis.
CEO of Repair Biotechnologies speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Reason discusses gene therapies to reverse immunosenescence and atherosclerosis.
Continue reading “Reason | Investing in the Age of Longevity 2019” »